Friday, June 27, 2014

Afrezza, a New Inhaled Insulin, Is Approved by F.D.A.

The approval is a huge milestone for MannKind Corporation but concerns linger about the drug’s potential effect on patients’ lungs.


via NYT > Business Day http://ift.tt/1iDMmPL








via WordPress http://ift.tt/1jX387g
Posted by at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)